Cargando…

Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up

BACKGROUND: There are few data on the mechanism of recurrent neurological events after transcatheter closure of patent foramen ovale (PFO) in cryptogenic stroke or TIA. METHODS: We retrospectively reviewed PFO closure procedures for the secondary prevention of cryptogenic stroke/TIA performed betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mariucci, Elisabetta, Donti, Andrea, Salomone, Luisa, Marcia, Marta, Guidarini, Marta, Formigari, Roberto, Prandstraller, Daniela, Balducci, Anna, Bronzetti, Gabriele, Bonvicini, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753007/ https://www.ncbi.nlm.nih.gov/pubmed/29430320 http://dx.doi.org/10.1155/2017/9849425

Ejemplares similares

Transcatheter Closure of PFO and ASD: Multimodality Imaging for Patient Selection and Perioperative Guidance
por: Egidy Assenza, Gabriele, et al.
Publicado: (2021)

Patent Foramen Ovale Related Cryptogenic Stroke during COVID-19 Disease in Three Patients: A Case Series
por: Palleri, Daniela, et al.
Publicado: (2021)

Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013)

Multidisciplinary assessment of patients with ischemic stroke, the structure of a stroke team, and first Egyptian experience in adults undergoing transcatheter PFO closure for PFO-related stroke
por: Mansour, Amr, et al.
Publicado: (2021)

Clinical and infarction patterns of PFO‐related cryptogenic strokes and a prediction model
por: He, Dan, et al.
Publicado: (2018)

Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study
por: Badoz, Marc, et al.
Publicado: (2023)

Percutaneous PFO closure for cryptogenic stroke in the setting of a systematic cardiac and neurological screening and a standardised follow-up protocol
por: Noble, Stéphane, et al.
Publicado: (2017)

Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke
por: Takafuji, Hiroya, et al.
Publicado: (2021)

Managing Patent Foramen Ovale (PFO) in Adults With Cryptogenic Stroke and Lymphoma: A Multidisciplinary Perspective
por: Khalid, Noman, et al.
Publicado: (2023)

Editorial: Patent Foramen Ovale (PFO) Closure for Prevention of Stroke
por: Kokkinidis, Damianos G., et al.
Publicado: (2021)

Editorial: Understanding PFO-associated stroke
por: Karapanayiotides, Theodoros, et al.
Publicado: (2023)

Pneumopericardium due to long sheath during transcatheter closure of PFO
por: Pac, FA, et al.
Publicado: (2010)

Investigation of Association between PFO Complicated by Cryptogenic Stroke and a Common Variant of the Cardiac Transcription Factor GATA4
por: Moradi Marjaneh, Mahdi, et al.
Publicado: (2011)

Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
por: Ratajczak‐Tretel, Barbara, et al.
Publicado: (2022)

Prior Stroke in PFO Patients Is Associated With Both PFO-Related and -Unrelated Factors
por: Kahles, Timo, et al.
Publicado: (2020)

Effect of history of atrial arrhythmias on the rate of recurrent stroke in patients after PFO closure
por: Jiravsky, O, et al.
Publicado: (2023)

Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
por: Ratajczak-Tretel, B, et al.
Publicado: (2022)

Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design
por: Khattab, Ahmed A, et al.
Publicado: (2011)

Rare Mechanical Complication of Percutaneous PFO Closure Leading to Recurrent Strokes in a Teenage Boy
por: Butt, Zaran, et al.
Publicado: (2021)

Clinical and brain magnetic resonance imaging long-term follow-up in patients with cryptogenic stroke undergoing PFO closure with the NobleStitch EL system. A single-centre experience
por: Arrivi, Alessio, et al.
Publicado: (2022)

Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study – the importance of comprehensive clinical evaluation
por: Ratajczak-Tretel, B., et al.
Publicado: (2023)

How to do when PFO closure failed under routine guidance: the first clinical experience for PFO closure
por: ZHOU, Ying, et al.
Publicado: (2021)

Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial
por: Kwon, Hanim, et al.
Publicado: (2021)

Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017)

Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials
por: Riaz, Irbaz Bin, et al.
Publicado: (2013)

Diagnostic Yield of TEE in Patients with Cryptogenic Stroke and TIA with Normal TTE: A Systematic Review and Meta-Analysis
por: Shah, Shamik, et al.
Publicado: (2021)

Stroke Prevention After Cryptogenic Stroke
por: Ibeh, Chinwe, et al.
Publicado: (2021)

Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events
por: Badea, Raluca Ştefania, et al.
Publicado: (2023)

Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019)

The ‘dreaded PFO’: anatomical and functional features of high risk for stroke
por: Radico, Francesco, et al.
Publicado: (2021)

“Migraine side effect” and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism
por: Kumor, Magdalena, et al.
Publicado: (2014)

Cryptogenic Stroke and Valvular Strands
por: Figueiredo, Cátia, et al.
Publicado: (2020)

Atrial Cardiopathy and Cryptogenic Stroke
por: Kato, Yuji, et al.
Publicado: (2022)

Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
por: Poli, Sven, et al.
Publicado: (2021)

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023)

Updated Meta-analysis on the Closure of Patent Foramen Ovale in Reduction of Stroke Rates: the DEFENSE-PFO Trial Does not Change the Scenario
por: Sá, Michel Pompeu Barros Oliveira, et al.
Publicado: (2018)

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?
por: Vemulapalli, Sreekanth, et al.
Publicado: (2018)

Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?
por: ARBOIX, Adrià, et al.
Publicado: (2021)

Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
por: Parrini, Iris, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mpaonkrdnff4616gfo5lpg113o